← Leaderboards
Marjorie Romkes
University Of Pittsburgh At Pittsburgh
$3,756,253
Attributed
$3,756,253
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $815.4K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,756,253 · 4
By mechanism
P50$3,007,113 · 3
R01$749,140 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Bernie Devlin$17,768,034
- Emanuela Taioli$7,168,480
- Jennifer R Grandis$109,711,044
- Marie D. Cornelius$5,636,640
- Brenda Diergaarde$4,504,466
Others in their field
Top investigators on “Dna Damage”
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- F Peter Guengerich · Vanderbilt University$33,973,148
- Aziz Sancar · University Of North Carolina Chapel Hill$31,216,731
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
- John A Tainer · Scripps Research Institute$27,554,249
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$27,391,656
Research focus
Dna DamageChemical CarcinogenGenotypeRegulationNucleotide Excision RepairProteinsMemberErcc2 GeneAllelesHalf-LifeAlternative SplicingMutationPathway InteractionsPredispositionCyclin D1Cell ProliferationBiological MarkersDna Excision Repair Protein Ercc-2FamilyGeneticRepairedCell Cycle ProteinsCell Cycle RegulationReporting
Grant awards (13)
P4 - NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LC RISK$318,828
P50 · FY2010 · CA · contact PI
P4 - NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LC RISK$318,835
P50 · FY2009 · CA · contact PI
Cyclin D1 & Xpd Polymorphism: Risk Factors Of Head & Neck Squamous Cell Carcinoma$495,855
P50 · FY2008 · CA · contact PI
NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LUNG CANCER RISK AND$319,590
P50 · FY2008 · CA · contact PI
Cyclin D1 & Xpd Polymorphism: Risk Factors Of Head & Neck Squamous Cell Carcinoma$461,606
P50 · FY2007 · CA · contact PI
NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LUNG CANCER RISK AND$322,674
P50 · FY2007 · CA · contact PI
NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LUNG CANCER RISK AND$205,170
P50 · FY2006 · CA · contact PI
CYCLIN D1 & XPD POLYMORPHISMS AS RISK FACTORS OF SCCHN$188,185
P50 · FY2006 · CA · contact PI
CYCLIN D1 &XPD POLYMORPHISMS AS RISK FACTORS OF SCCHN$188,185
P50 · FY2005 · CA
CYCLIN D1 AND XPD POLYMORPHISMS AS POTENTIAL RISK FACTORS OF SCCHN$188,185
P50 · FY2004 · CA
PHARMACOGENETIC DETERMINANTS OF FETAL SOMATIC MUTATION$256,856
R01 · FY2002 · HD
PHARMACOGENETIC DETERMINANTS OF FETAL SOMATIC MUTATION$249,643
R01 · FY2001 · HD
PHARMACOGENETIC DETERMINANTS OF FETAL SOMATIC MUTATION$242,641
R01 · FY2000 · HD